NCT06021990View on ClinicalTrials.gov

Clopidogrel for the Prevention of Exacerbations in Severe COPD

PHASE3RecruitingINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

December 31, 2024

Conditions
COPDCOPD Exacerbation Acute
Interventions
DRUG

Clopidogrel Bisulfate 75Mg Tab

Severe COPD patients who meet eligibility criteria will be given Clopidogrel Bisulfate 75 mg Tablet daily, along with standard of care treatment till the completion of the study duration or any side effects that warrants stoppage of the drug

Trial Locations (2)

19110

RECRUITING

Saidu Teaching Hospital, Swat, Swāt

25000

RECRUITING

Pulmonology Department, Lady Reading Hospital, Peshawar, Peshawar

All Listed Sponsors
collaborator

Pakistan Chest Society, Pakistan

UNKNOWN

lead

Lady Reading Hospital, Pakistan

OTHER_GOV